Viracta Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2024 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Viracta Therapeutics, Inc. Earnings Date And Information
Viracta Therapeutics, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.35 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Viracta Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.32 diluted earnings per share) and currently has a price-to-earnings ratio of -0.14. Viracta Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Viracta Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.27 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.35 | -$0.25 | 0.1 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.35 | -$0.23 | 0.12 | $0 | |
| 03/07/2024 | Q4 2023 | -$0.30 | -$0.35 | -0.05 | $738,000 | |
| 11/09/2023 | Q3 2023 | -$0.33 | -$0.33 | 0 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.30 | -$0.32 | -0.02 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.34 | $0 | |||
| 03/14/2023 | Q4 2022 | -$0.27 | $0 | |||
| 11/10/2022 | Q3 2022 | -$0.31 | -$0.46 | -0.15 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.30 | -$0.28 | 0.02 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.32 | -$0.28 | 0.04 | $0 | |
| 03/16/2022 | Q4 2021 | -$0.31 | $0 | |||
| 11/10/2021 | Q3 2021 | -$0.31 | -$0.40 | -0.09 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.24 | -$0.25 | -0.01 | $0 | |
| 05/13/2021 | Q1 2021 | -$5.22 | $0 | |||
| 02/24/2021 | Q4 2020 | -$0.96 | -$0.41 | 0.55 | $0 | |
| 11/16/2020 | Q3 2020 | -$1.18 | -$0.11 | 1.07 | $0 | |
| 08/11/2020 | Q2 2020 | -$1.94 | -$0.11 | 1.83 | $375,000 | $0 |
| 05/07/2020 | Q1 2020 | -$2.44 | -$0.12 | 2.32 | $120,000 | |
| 03/10/2020 | Q4 2019 | -$2.58 | -$0.48 | 2.1 | $2.07 M |
Viracta Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Viracta Therapeutics, Inc.'s earnings date?
Viracta Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
Did Viracta Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Viracta Therapeutics, Inc. (:VIRX) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.35 by $0.1.
-
How can I listen to Viracta Therapeutics, Inc.'s earnings conference call?
The conference call for Viracta Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Viracta Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Viracta Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Viracta Therapeutics, Inc. generate each year?
Viracta Therapeutics, Inc. (:VIRX) has a recorded net income of $0. Viracta Therapeutics, Inc. has generated $-1.32 earnings per share over the last four quarters.
-
What is Viracta Therapeutics, Inc.'s price-to-earnings ratio?
Viracta Therapeutics, Inc. (:VIRX) has a price-to-earnings ratio of -0.14 and price/earnings-to-growth ratio is -0.03.
